Resultados de la búsqueda 121-130 of 17419 for monoclonal antibody

1. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... antibodies against the study drug (which ... Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...